Concepedia

Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets

Caroline Gest, Pezhman Mirshahi, Hong Li, Linda-Louise Pritchard, Ulrich Joimel, Emmanuel Blot, Jean Chidiac, Bernard Poletto, Jean‐Pierre Vannier, R. Varin,

Cancer Letters · 2011 · 31 citations · 44 references

DOI

Concepts

References

44

Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid

Donald R. Senger, Stephen J. Galli, Ann M. Dvořàk et al. · Science · 1983 · 4K citations

, , +13

HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line

Edwin W. Ades, Francisco J. Candal, Robert A. Swerlick et al. · Journal of Investigative Dermatology · 1992 · 1.3K citations

, , +4

A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer

Andreas du Bois · JNCI Journal of the National Cancer Institute · 2003 · 1.1K citations · Full text

, , +17

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

Marcus Bantscheff, Dirk Eberhard, Yann Abraham et al. · Nature Biotechnology · 2007 · 1K citations

, , +14

Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells

Mark Bond · Cardiovascular Research · 2001 · 367 citations · Full text

, , +17